Valuation: Medios AG

Market Cap 298M 341M 275M 254M 483M 32.51B 491M 3.29B 1.29B 15.97B 1.28B 1.25B 55.31B P/E 2026 *
11x
P/E 2027 * 8.71x
Enterprise Value 374M 428M 345M 319M 606M 40.82B 616M 4.13B 1.62B 20.05B 1.61B 1.57B 69.44B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.16x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day-0.82%
1 week-2.98%
Current month-0.25%
1 month-1.07%
3 months-7.31%
6 months-21.65%
Current year-16.78%
1 week 11.8
Extreme 11.8
13
1 month 11.8
Extreme 11.8
13
Current year 11.64
Extreme 11.64
17.44
1 year 11.64
Extreme 11.64
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap.
02-04Sell

Chief Executive Officer

13,638 0.0535%
01-22Buy

Executive/Senior Manager

4,000 0.0157%
19/08/24Buy

Executive/Senior Manager

10,000 0.0392%
Change 5-day change 1-year change 3-year change Capi.($)
-0.82%-2.98%-5.56%-26.79% 341M
+0.09%+0.25%+54.65%+169.19% 1,085B
-1.63%-1.50%+65.79%+62.70% 624B
-1.12%-4.27%+31.10%+84.44% 442B
+1.07%-0.38%+29.01%+27.92% 332B
-1.52%-9.02%+23.77%+29.19% 277B
+0.67%-2.10%+26.24%+46.00% 282B
+0.77%-1.33%-29.20%-39.24% 217B
-1.19%-2.81%+22.63%+66.30% 196B
-0.72%+2.72%+19.07%+81.19% 167B
Average -0.16%-1.74%+23.75%+50.09% 362.23B
Weighted average by Cap. +0.19%-1.06%+38.37%+85.14%

Financials

2026 *2027 *
Net sales 2.08B 2.38B 1.92B 1.78B 3.37B 227B 3.43B 22.99B 9.01B 112B 8.93B 8.74B 386B 2.14B 2.44B 1.97B 1.82B 3.46B 233B 3.52B 23.61B 9.26B 115B 9.18B 8.98B 397B
Net income 27.41M 31.33M 25.27M 23.38M 44.38M 2.99B 45.13M 303M 119M 1.47B 118M 115M 5.09B 34.51M 39.45M 31.82M 29.44M 55.88M 3.77B 56.82M 381M 149M 1.85B 148M 145M 6.4B
Net Debt 76.15M 87.05M 70.23M 64.98M 123M 8.31B 125M 841M 330M 4.08B 327M 320M 14.13B 40.72M 46.55M 37.55M 34.75M 65.95M 4.44B 67.05M 450M 176M 2.18B 175M 171M 7.56B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
993
Date Price Change Volume
10/07/26 12.05 -0.90% 7,113
09/07/26 €12.16 +1.84% 23,498
08/07/26 €11.94 -0.83% 21,845
07/07/26 €12.04 -3.22% 17,156
06/07/26 €12.44 +0.16% 29,760
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.16EUR
Average target price
23.00EUR
Spread / Average Target
+89.14%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock